DRUG COALITION: Mayo Clinic has joined a coalition of hospitals in launching Civica Rx, a not-for-profit generic drug company that will help patients by addressing shortages and high prices of lifesaving medications. The company, which is organized as a Delaware nonstock, not-for-profit corporation, will be headquartered in Utah.
Civica Rx, a manufacturer approved by the Food and Drug Administration, will directly manufacture generic drugs or subcontract manufacturing to reputable contract manufacturing organizations.
Civica Rx has identified 14 hospital-administered generic drugs as the initial focus of its efforts. Civica Rx expects to have its first products on the market as early as 2019. The company also will provide generic medications to the retail market, offering an affordable alternative to products from incumbent generic drug companies.
“This endeavor demonstrates the need for collaboration to solve the most complex health care challenges of today,” said Dr. John Noseworthy, president and CEO, Mayo Clinic. “I am pleased to see our collective commitment to improving the health and well-being of millions of patients come alive through this mission-driven initiative.”
Civica Rx first will seek to stabilize the supply of essential generic medications administered in hospitals — many of which have fallen into chronic shortage situations. These shortages put patients at risk.
The initiative also aims to lower the costs and enable more predictable supplies of essential generic medicines, helping ensure that patient needs come first.
Since the initiative was announced in early 2018, more than 120 health organizations representing about one-third of the nation’s hospitals have contacted Civica Rx and expressed a commitment or interest in participating with the new company. Civica Rx is collaborating with the American Hospital Association’s newly formed Center for Health Innovation to address inquiries about the initiative.
In addition to Mayo Clinic, other initial governing members of Civica Rx are Catholic Health Initiatives, Hospital Corporation of America, Intermountain Healthcare, Providence St. Joseph Health, SSM Health and Trinity Health.
These organizations, representing about 500 U.S. hospitals, will provide leadership for the Civica Rx board of directors and much of the initial capitalization for the company.
The Department of Veterans Affairs also will work in consultation with Civica Rx to address its needs. Other health systems participating with Civica Rx will be announced later this year.
Three major philanthropies will also join Civica Rx as governing members: the Laura and John Arnold Foundation, the Peterson Center on Healthcare and the Gary and Mary West Foundation. The engagement of philanthropic members is intended to further support and safeguard the company’s not-for-profit, social welfare mission.
• • •
PERFORMANCE TRAINING: Athletes from middle school through college can receive performance training at Mayo Clinic Health System sites in Eau Claire and Menomonie this fall. Clinics are held from 3:30 to 4:30 p.m. Tuesdays and Thursdays, Sept. 25 through Nov. 1. The cost is $120.
The six-week performance training program is designed to improve various aspects of athletic performance, including agility, confidence, jumping, strength and increased linear and multidirectional speed. Program locations include:
• Eau Claire: 1400 Bellinger St., Rehabilitation Services, lower level.
• Menomonie: 2407 Stout Road, Rehabilitation Services, first floor.
To register or for more information, call 715-233-7753.
• • •
‘REC THE PARK’: Get active and enjoy recreation opportunities during a free “Rec the Park” event from 3 to 5 p.m. Sunday, Sept. 23, at McDonough Park, 800 Centre St.
Participants can enjoy a leisurely walk on the trail; challenge their family in the obstacle course; play yard games such as kubb, bean bag toss, spikeball and kan jam; and more.
The event is for participants age 10 and up. Instruction will be offered.
The event is co-supported by Eau Claire Parks, Recreation & Forestry and Mayo Clinic Health System.
• • •
DISEASE REPORT: For the three-month period ending June 30, the Eau Claire City-County Health Department received reports of 121 cases of chlamydia.
During that same period, 50 cases of gonorrhea, 32 cases of hepatitis C, 24 cases of E. coli, pathogenic, 17 cases of cyclospora, 16 cases of influenza-associated hospitalization, 14 cases of Lyme disease and 13 cases of campylobacter were reported.
Other communicable diseases reported were: nine cases, streptococcal groups A and B invasive disease; eight cases, anaplasmosis; seven cases, salmonella; six cases each, ehrlichiosis chaffeensis, mycobacterial disease (non-tuberculous) and streptococcal pneumoniae invasive disease; four cases each, cryptosporidium, pertussis and tuberculosis, latent infection; two cases each, ehrlichiosis undetermined, giardia, hepatitis B, shigella, tuberculosis, class A or B, and yersiniosis; and one case each, ehrlichiosis muris-like, haemophilus influenzae invasive disease, Kawasaki disease, syphilis, vancomycin-intermediate stapylococcus aureus and varicella.
Not all cases of tuberculosis, latent infection, and varicella are reported to the health department.
From staff reports